• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光学相干断层扫描血管造影中息肉内血流信号与息肉状脉络膜血管病变联合治疗后反应的相关性。

ASSOCIATION OF FLOW SIGNALS WITHIN POLYPS ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH TREATMENT RESPONSES AFTER COMBINATION THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.

机构信息

Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Japan .

出版信息

Retina. 2022 May 1;42(5):942-948. doi: 10.1097/IAE.0000000000003395.

DOI:10.1097/IAE.0000000000003395
PMID:34954774
Abstract

PURPOSE

To evaluate the changes of blood circulation within the polypoidal lesions by OCT angiography in eyes with polypoidal choroidal vasculopathy after combination therapy with aflibercept and photodynamic therapy.

METHODS

A total of 46 eyes from 46 patients who underwent the combination therapy for polypoidal choroidal vasculopathy were followed for more than 6 months. OCT angiography, covering an area 6 mm2 × 6 mm2 including the macula, were performed at baseline, 2 weeks, and 3 months and 6 months post-treatment.

RESULTS

The subretinal fluid resolved within 3 months after treatment in 44 eyes (95.7%), and 27 eyes (58.7%) showed no recurrence, with no additional treatment. Seventeen eyes (37.0%) showed recurrence, and two eyes (4.3%) showed poor response. On OCT angiography at 2 weeks after treatment, flow signals were detected in 3 of 27 eyes (11.1%) without recurrence and in 8 of 19 eyes (42.1%) with recurrence or poor responses. A detectable flow signal at 2 weeks was significantly associated with recurrence or poor response (P = 0.032).

CONCLUSION

Persistent flow signals within polyps on OCT angiography at 2 weeks after combination therapy suggest less effectiveness of the initial treatment.

摘要

目的

通过 OCT 血管造影评估接受抗 VEGF 联合光动力疗法治疗后的息肉状脉络膜血管病变患者息肉状病变内血液循环的变化。

方法

对 46 例(46 只眼)接受抗 VEGF 联合光动力疗法治疗的息肉状脉络膜血管病变患者进行了超过 6 个月的随访。在基线、治疗后 2 周、3 个月和 6 个月时进行 OCT 血管造影检查,覆盖黄斑区 6mm2×6mm2 区域。

结果

44 只眼(95.7%)的视网膜下液在治疗后 3 个月内消退,27 只眼(58.7%)无复发,无需额外治疗。17 只眼(37.0%)出现复发,2 只眼(4.3%)出现治疗反应不佳。在治疗后 2 周的 OCT 血管造影检查中,无复发的 27 只眼中有 3 只(11.1%)眼和复发或治疗反应不佳的 19 只眼中有 8 只(42.1%)眼检测到血流信号。在 2 周时检测到血流信号与复发或治疗反应不佳显著相关(P=0.032)。

结论

治疗后 2 周 OCT 血管造影检查显示息肉内持续存在血流信号提示初始治疗效果不佳。

相似文献

1
ASSOCIATION OF FLOW SIGNALS WITHIN POLYPS ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH TREATMENT RESPONSES AFTER COMBINATION THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.光学相干断层扫描血管造影中息肉内血流信号与息肉状脉络膜血管病变联合治疗后反应的相关性。
Retina. 2022 May 1;42(5):942-948. doi: 10.1097/IAE.0000000000003395.
2
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS OF CLASSIC CHOROIDAL NEOVASCULARIZATION IN POLYPOIDAL CHOROIDAL VASCULOPATHY.光学相干断层扫描血管造影在息肉状脉络膜血管病变中的典型脉络膜新生血管的表现。
Retina. 2022 Jan 1;42(1):123-128. doi: 10.1097/IAE.0000000000003264.
3
Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.玻璃体内阿柏西普治疗后息肉样脉络膜血管病变完全息肉样消退的时间。
Ophthalmol Retina. 2022 Jan;6(1):21-28. doi: 10.1016/j.oret.2021.03.012. Epub 2021 Mar 27.
4
OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT.光相干断层扫描在阿柏西普治疗息肉状脉络膜血管病变中对息肉样病变闭合的特征。
Retina. 2022 Jan 1;42(1):114-122. doi: 10.1097/IAE.0000000000003285.
5
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION.息肉状脉络膜血管病变和息肉状脉络膜新生血管的光学相干断层扫描血管造影
Retina. 2015 Nov;35(11):2265-74. doi: 10.1097/IAE.0000000000000777.
6
IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.采用光学相干断层扫描和光学相干断层扫描血管造影相结合的方法提高息肉状脉络膜血管病变的检测和诊断。
Retina. 2019 Sep;39(9):1655-1663. doi: 10.1097/IAE.0000000000002228.
7
Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.吲哚菁绿血管造影与玻璃体内雷珠单抗治疗息肉状脉络膜血管病变后光学相干断层扫描结果的相关性。
Retina. 2012 Nov-Dec;32(10):2006-13. doi: 10.1097/IAE.0b013e31825c1c31.
8
CHARACTERIZATION AND DIFFERENTIATION OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.使用扫频源光学相干断层扫描血管造影术对息肉样脉络膜血管病变进行特征描述与鉴别诊断
Retina. 2017 Aug;37(8):1464-1474. doi: 10.1097/IAE.0000000000001391.
9
Progression of Polypoidal Lesions Associated with Exudative Recurrence in Polypoidal Choroidal Vasculopathy.息肉样病变与息肉样脉络膜血管病变渗出性复发相关的进展。
Ophthalmology. 2023 Feb;130(2):167-178. doi: 10.1016/j.ophtha.2022.09.013. Epub 2022 Sep 22.
10
Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.利用 OCT B 扫描区分渗出性年龄相关性黄斑变性和息肉样脉络膜血管病变。
Ophthalmol Retina. 2021 Oct;5(10):954-961. doi: 10.1016/j.oret.2021.05.009. Epub 2021 May 19.

引用本文的文献

1
Predicting treatment outcomes of intravitreal brolucizumab for polypoidal choroidal vasculopathy through noninvasive assessment of polypoidal lesion blood flow with optical coherence tomography angiography.利用光相干断层扫描血管造影术无创评估息肉样脉络膜血管病变血流预测玻璃体内布罗利珠单抗治疗效果。
Sci Rep. 2024 Jan 10;14(1):961. doi: 10.1038/s41598-024-51628-0.
2
Advances in multi-modal non-invasive imaging techniques in the diagnosis and treatment of polypoidal choroidal vasculopathy.多模态无创成像技术在息肉样脉络膜血管病变诊断与治疗中的进展
Front Med (Lausanne). 2023 Jul 27;10:1221846. doi: 10.3389/fmed.2023.1221846. eCollection 2023.
3
Recent Advances in Imaging Polypoidal Choroidal Vasculopathy with Swept-Source Optical Coherence Tomography Angiography.
扫频源光学相干断层扫描血管造影术在息肉样脉络膜血管病变成像中的最新进展
Diagnostics (Basel). 2023 Jul 24;13(14):2458. doi: 10.3390/diagnostics13142458.